NSAV Archives - Page 6 of 8 - Blue Horseshoe Stocks

Options Reviews, Fresh Ideas

Options Runners:

We’re ready to kick off a fresh trading week today, but before we can dive into what’s looking ripe for the picking this morning, of course we need to go over the solid gains that occurred in our targeted options plays from Friday morning’s premarket report.

Three of our four designated set of options ideas on the day panned out to some significant gain opportunities for us. We were looking at the EXPE Weekly $202.50-207.50 Calls, the F Weekly $17.50-18 Calls, and the NET Weekly $119-122 Calls. The moves we witnessed weren’t eye-popping, but they were very respectable, especially considering how poorly things went for the markets in general.

Here were the total intraday runs and possible profits associated with those targets:

EXPE Weekly $202.50-207.50 Calls
$202.50: 1.69-4.75 (+181%)
$205: .97-3.00 (+209%)
$207.50: .59-1.74 (+195%)
_____

F Weekly $17.50-18 Calls
$17.50: .54-.86 (+59%)
$18: .18-.39 (+116%)
_____

NET Weekly $119-122 Calls
$119: .47-1.20 (+155%)
$120: .28-.98 (+250%)
$121: .29-.69 (+138%)
$122: .20-.50 (+150%)

Fresh Options Ideas:
PBR Weekly $14-14.50 Calls
GT Weekly $15.50-16.50 Calls
WEBR Weekly $10 Puts

Extended Watchlist:
TCBP, SOPI, MOTS, KAVL, BDSI, CNR, KSCP, UCPA, IGEX, NSAV, EEGI, ILIN

Starting 2022 Off the Right Way

Ringing in the New Year with Options Updates

We’ve been tracking several longer-term options plays in recent sessions, and today for the first report of the new calendar year, we’ve got some updates on the moves we’ve observed.

Starting off with BBIO, we were on top of that one from Tuesday of last week, watching as it gradually pressed to new highs each day. The stock itself has run from 12.06-17.34 during that span (+44%). We were targeting the BBIO 02/18 $12.50-15 Calls and thus far here are the total increases we’ve observed in those plays:

BBIO 02/18 $12.50-15 Calls
$12.50: 1.85-5.11 (+176%)
$15: 1.50-3.60 (+140%)

On the same day last Tuesday, we signaled interest in some MRNA targets as well, highlighting the MRNA 01/21 $250-260 Calls and they too produced some nice increases on the week when all was said and done.

MRNA 01/21 $250-260 Calls
$250: 11.45-22.04 (+92%)
$252.50: 11.17-20.00 (+79%)
$255: 10.21-19.04 (+86%)
$257.50: 10.55-17.90 (+70%)
$260: 9.10-17.00 (+87%)

Fresh Options Ideas:
SPY 01/03 $476-478 Calls*
FB Weekly $337.50-340 Calls

*Please don’t attempt to trade options on the day of their expiration unless you are an experienced trader with access to disposable funds!

Extended Watchlist:
IMMX, CELZ, BLCT, AFI, PTE, HMBL, IQST, PRMK, RGBP, BLFE, NSAV, AMLH

Potential Swing Trades to Track into 2022

Bottom Play Options Candidates:

The winter holiday season is upon us, and it has been tough sledding over the past week with regard to the low amount of daily earnings reporters. Unfortunately, this down period is going to persist for the next month, but we will still make every effort to scout out and formulate trading ideas. We’ve gotten through other earnings dry spells before, and we’ll do it again this time as well!

Typically when there are no earnings to fuel intraday volatility that we can use to our advantage, we search for insider trading, and favorable technical setups as the next best thing. We’ve got some fresh ideas today that fall into both of those categories, with insider trades recently logged in VZIO and ETLB, and an interesting chart setup on TKR.

All three of these qualify as bottom plays that are going to be prime swing trade candidates to track into the new year:

TKR 01/21 $65-70 Calls
VZIO 01/21 $19-20 Calls
ETLB 01/21 $80-85 Calls

Extended Watchlist:
ICOA, NSAV, CCWF, TIPS, GRTX, GMTX, BFRI, CFVI, AVCT, NRPI, ICOA

Multiple Key Updates & Big Runners

Medigus, Ltd. MDGS – News Alert:

We’ve got more fresh news hitting the wires this morning from MDGS. One of the things we like best about the company is the frequency with which it communicates with its shareholders.

Today’s release pertains to the hiring of an advisory firm to guide Polyrizon, in which Medigus is a stakeholder, toward FDA approval for its nasal gels which are preventative against viruses, including COVID-19 and the flu.

Tel Aviv, Israel, Oct. 22, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Polyrizon Ltd., (37.01%), that it has engaged with a full-service Contract Research Organisation (CRO), to advise the Company in its pursuit of Food and Drug Administration (FDA) submission for its products. (>>View Full PR)

Watchlist Updates:

We typically encourage our readers to keep track of not only the featured items in our daily reports, but our ‘Extended Watchlists’ as well. They often include hidden opportunities waiting to be unearthed.

Such was the case yesterday with DWAC, which was included in our premarket report before exploding from a daily low of 12.62 up as high as 52.00. That works out to an intraday run of 312% Our overall observed range has increased already this morning with a premarket high of 93.43, which marks a rise of 640%

We also signaled MGTI on Monday morning, and it has posted a solid intraweek performance thus far. The stock came up from a low of .041 to a high of .064, an increase of 58%

Options Recap:

Last but not least, we went three for three on options ideas in yesterday’s report, which provided the following intraday gain opportunities for our readers:

CSX Weekly $34-36 Calls
$34: 1.30-1.84 (+42%)
$35: .45-.90 (+100%)
$36: .05-.24 (+380%)
_____

BX Weekly $130-133 Calls
$130: 2.50-4.83 (+93%)
$131: 1.69-3.67 (+117%)
$132: .93-3.05 (+228%)
$133: .72-2.32 (+222%)
_____

T Weekly $25.50-26.50 Calls
$25.50: .20-.34 (+70%)
$26: .15-.36 (+140%)
$26.50: .05-.11 (+120%)
_____

Fresh Options Ideas:
STX Weekly $82.50-85 Calls
AXP Weekly $177.50-182.50 Calls

Extended Watchlist:
PHUN, CRTD, GROM, DATS, CZNI, SEGI, TONR, ASTI, NSAV, CIVX, CAGC

Closing Out Another Excellent Trading Week

Solid Options Sweep:

We posted another clean sweep on options ideas in yesterday’s premarket report, offering up a pair of fresh ideas, and knocking them both out of the park with multi-bag gain opportunities on the day!

We were specifically targeting the DRI 10/15 $155-160 Calls and the ACN Weekly $337.50-342.50 Calls, on the heels of the companies’ earnings reports. Despite being in a relative down-period for earnings reporters, we have been able to work with what we’ve got.

Here are the total possible intraday gains that were on the table for those ideas yesterday:

DRI 10/15 $155-160 Calls
$155: 5.00-10.22 (+104%)
$160: 1.85-6.70 (+262%)
_____

ACN Weekly $337.50-342.50 Calls
$337.50: 2.63-7.30 (+178%)
$340: 1.40-5.40 (+286%)
$342.50: .90-3.00 (+233%)

Eargo, Inc. EAR – Bottom Watch:

We’re also looking at a possible long term recovery play in EAR, which got severely beaten up yesterday with a major gap-down. It may end up being a decent bottom play for the stock itself but we’re going to signal a longer-term options idea to track as well, in the EAR 11/19 $7.50-10 Calls.

Fresh Options Ideas:
NKE Weekly $155-152.50 Puts*
COST Weekly $452.50-457.50 Calls*
SKX Weekly $48-46 Puts*

*Do not attempt to trade options contracts on their day of expiration unless you are an advanced level trader with access to disposable funds

Extended Watchlist:
ILUS, FERN, NSAV, CFGX, BANT, INTV, NOUV, PRMO, NBRI, ZIVO, CAPR, VTVT, UFAB